These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3688282)

  • 1. Dysphoria associated with methylphenidate infusion in borderline personality disorder.
    Lucas PB; Gardner DL; Wolkowitz OM; Cowdry RW
    Am J Psychiatry; 1987 Dec; 144(12):1577-9. PubMed ID: 3688282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysphoria associated with methylphenidate infusions.
    Robinson D; Bailine S; Lieberman J
    Am J Psychiatry; 1988 Oct; 145(10):1321-2. PubMed ID: 3421369
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Object relations, defensive operations, and affective states in narcissistic, borderline, and antisocial personality disorder.
    Gacono CB; Meloy JR; Berg JL
    J Pers Assess; 1992 Aug; 59(1):32-49. PubMed ID: 1512679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotic symptoms in borderline personality disorder.
    Chopra HD; Beatson JA
    Am J Psychiatry; 1986 Dec; 143(12):1605-7. PubMed ID: 3789216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults.
    Wender PH; Reimherr FW; Wood D; Ward M
    Am J Psychiatry; 1985 May; 142(5):547-52. PubMed ID: 3885760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual practices among patients with borderline personality disorder.
    Zubenko GS; George AW; Soloff PH; Schulz P
    Am J Psychiatry; 1987 Jun; 144(6):748-52. PubMed ID: 3591995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive response to physostigmine challenge in borderline personality disorder patients.
    Steinberg BJ; Trestman R; Mitropoulou V; Serby M; Silverman J; Coccaro E; Weston S; de Vegvar M; Siever LJ
    Neuropsychopharmacology; 1997 Oct; 17(4):264-73. PubMed ID: 9326751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An empirical study of psychosis in borderline personality disorder.
    Pope HG; Jonas JM; Hudson JI; Cohen BM; Tohen M
    Am J Psychiatry; 1985 Nov; 142(11):1285-90. PubMed ID: 4061687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic-induced dysphoric response in non-schizophrenic patients].
    Berardi D; Zanfini R; Alessi S; Giannelli A; Ferrari G
    Minerva Psichiatr; 1993 Jun; 34(2):125-33. PubMed ID: 8105358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing affective instability in borderline personality disorder.
    Koenigsberg HW; Harvey PD; Mitropoulou V; Schmeidler J; New AS; Goodman M; Silverman JM; Serby M; Schopick F; Siever LJ
    Am J Psychiatry; 2002 May; 159(5):784-8. PubMed ID: 11986132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and distinctness of borderline personality disorder.
    Barasch A; Frances A; Hurt S; Clarkin J; Cohen S
    Am J Psychiatry; 1985 Dec; 142(12):1484-6. PubMed ID: 4073317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study.
    Zanarini MC; Frankenburg FR; Reich DB; Silk KR; Hudson JI; McSweeney LB
    Am J Psychiatry; 2007 Jun; 164(6):929-35. PubMed ID: 17541053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The course of dysphoric affective and cognitive states in borderline personality disorder: a 10-year follow-up study.
    Reed LI; Fitzmaurice G; Zanarini MC
    Psychiatry Res; 2012 Mar; 196(1):96-100. PubMed ID: 22326877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.
    Nickel MK; Muehlbacher M; Nickel C; Kettler C; Pedrosa Gil F; Bachler E; Buschmann W; Rother N; Fartacek R; Egger C; Anvar J; Rother WK; Loew TH; Kaplan P
    Am J Psychiatry; 2006 May; 163(5):833-8. PubMed ID: 16648324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder.
    Zanarini MC; Frankenburg FR; Hennen J; Silk KR
    Am J Psychiatry; 2003 Feb; 160(2):274-83. PubMed ID: 12562573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation, trauma, affect regulation and personality in patients with a borderline personality organization.
    Löffler-Stastka H; Szerencsics M; Blüml V
    Bull Menninger Clin; 2009; 73(2):81-98. PubMed ID: 19604074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing depression in borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM
    J Clin Psychiatry; 1987 Apr; 48(4):155-7. PubMed ID: 3558327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effects of amitriptyline on borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
    Am J Psychiatry; 1986 Dec; 143(12):1603-5. PubMed ID: 3538914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and panic in patients with borderline personality disorder.
    Grunhaus L; King D; Greden JF; Flegel P
    Biol Psychiatry; 1985 Jun; 20(6):688-92. PubMed ID: 3995116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.